Hawkeye Announces Letter of Intent to Acquire Six15 Technologies

Hawkeye Systems, Inc. (OTCQB:HWKE) (“Hawkeye”), a technology holding company, is pleased to announce today it has signed a Letter of Intent (LOI) to acquire Six15 Technologies (“Six15”), a technology company that designs, develops, and manufactures head-up displays (HUDs) for enterprise and defense users.

Hawkeye is currently expediting the completion of due diligence to finalize a definitive Agreement (“Agreement”) to complete an all-stock purchase of 100% of the shares of Six15. The Agreement will effectuate a reverse reorganization of the two companies in conjunction with an proposed growth capital financing.

Corby Marshall, CEO of Hawkeye, stated, “We are pleased to reach the successful culmination of our M&A process with the announcement of a truly robust growth acquisition opportunity in Six15.

Combining world-class technology with accomplished industry leadership, the Six15 Agreement is expected to return the Company to its original tech mission and its focus on building sustainable long- term shareholder value.”

Rich Ryan, CEO of Six15, commented, “We view the anticipated Agreement and subsequent capital raise as the final element needed to catalyze the hyper-growth phase of our business plan. We further believe our evolving narrative will be well-suited to attract and build long-term investor interest as a public company.”

Hawkeye anticipates there will be a name and symbol change as part of the transaction. A reverse stock split is also being discussed.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.